Osteoporosis Treatment After Hip Fracture
Author Information
Author(s): Robert J Petrella, Tim J Jones
Primary Institution: University of Western Ontario
Hypothesis
The study aimed to identify missed opportunities for osteoporosis treatment in patients after hip fractures.
Conclusion
Most patients who suffered a hip fracture were not on recommended osteoporosis therapy at admission or 12 months post-discharge.
Supporting Evidence
- Only 7 patients had previous BMD assessments.
- At six weeks, a significant decrease in calcium and vitamin D use was observed.
- 71 patients remained on residronate at twelve months.
Takeaway
The study found that many people who broke their hip didn't get the medicine they needed to help their bones, even though doctors knew they should.
Methodology
A prospective study was conducted with patients admitted for hip fracture rehabilitation to evaluate the use of osteoporosis treatments over one year.
Potential Biases
Potential clinical inertia among physicians and misconceptions about ongoing treatment may have affected results.
Limitations
The study may not represent all patients with osteoporosis as it focused on those admitted for hip fractures.
Participant Demographics
Mean age of participants was 83 years, with 78% being female.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website